ZERUN CO., LTD — Investor Relations & Filings
ZERUN CO., LTD. specializes in the research, development, and commercialization of innovative human vaccines. The organization utilizes advanced recombinant protein technology platforms to address significant public health challenges. Its primary product portfolio includes human papillomavirus (HPV) vaccines, specifically bivalent and nonavalent candidates designed to prevent cervical cancer. ZERUN CO., LTD. emphasizes the production of high-quality, affordable biological products to support global immunization efforts. The organization maintains rigorous quality control standards and operates large-scale manufacturing facilities to ensure the stable supply of preventive medicines. By leveraging its proprietary technical expertise, the company aims to improve health outcomes through the prevention of infectious diseases and virus-related malignancies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年年度审计报告 | 2026-04-28 | Chinese | |
| 申万宏源证券承销保荐有限责任公司关于江苏泽润新能科技股份有限公司使用部分闲置募集资金及自有资金进行现金管理的核查意见 | 2026-04-28 | Chinese | |
| 关于使用部分闲置募集资金及自有资金进行现金管理的公告 | 2026-04-28 | Chinese | |
| 2025年度内部控制评价报告 | 2026-04-28 | Chinese | |
| 委托理财管理制度 | 2026-04-28 | Chinese | |
| 关于2026年度公司及子公司向银行申请综合授信额度的公告 | 2026-04-28 | Chinese |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39596519 | 2025年年度审计报告 | 2026-04-28 | Chinese | ||
| 39596508 | 申万宏源证券承销保荐有限责任公司关于江苏泽润新能科技股份有限公司使用部分闲置募集资金及自有资金进行现金管理的核查意见 | 2026-04-28 | Chinese | ||
| 39596500 | 关于使用部分闲置募集资金及自有资金进行现金管理的公告 | 2026-04-28 | Chinese | ||
| 39596496 | 2025年度内部控制评价报告 | 2026-04-28 | Chinese | ||
| 39596488 | 委托理财管理制度 | 2026-04-28 | Chinese | ||
| 39596482 | 关于2026年度公司及子公司向银行申请综合授信额度的公告 | 2026-04-28 | Chinese | ||
| 39596476 | 关于相关股东延长股份锁定期的公告 | 2026-04-28 | Chinese | ||
| 39596468 | 关于开展外汇衍生品交易及商品期货套期保值业务的可行性分析报告 | 2026-04-28 | Chinese | ||
| 39596460 | 关于召开2025年年度股东会的通知 | 2026-04-28 | Chinese | ||
| 39596453 | 关于2025年度拟不进行利润分配的专项说明 | 2026-04-28 | Chinese | ||
| 39596449 | 2026年一季度报告 | 2026-04-28 | Chinese | ||
| 39596443 | 2025年年度报告摘要 | 2026-04-28 | Chinese | ||
| 39596437 | 关于延期披露2025年年度报告及2026年第一季度报告的公告 | 2026-04-23 | Chinese | ||
| 39596436 | 股票交易异常波动公告 | 2026-02-04 | Chinese | ||
| 39596432 | 2025年度业绩预告 | 2026-01-29 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ZERUN CO., LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56405/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56405 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56405 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56405 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56405}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ZERUN CO., LTD (id: 56405)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.